7. Hims & Hers Health Inc. (NYSE:HIMS)
Hims & Hers Health, Inc. (NYSE: HIMS) claims seventh place as a fast-growing consumer healthcare platform using technology and artificial intelligence to expand access to personalized treatment.
The company provides services across weight management, sexual health, hair care, dermatology, mental health and other consumer-health categories. Patients complete digital assessments, connect with healthcare professionals and receive treatments through an integrated online platform.
Artificial intelligence supports patient intake, treatment personalization, provider workflows and the company’s effort to serve a growing subscriber base without allowing administrative costs to rise at the same pace.
Second-quarter 2026 revenue reached approximately $753 million and exceeded market expectations. The company added more than 300,000 subscribers and raised its annual revenue forecast to between $3.1 billion and $3.3 billion.
Management is targeting at least $6.5 billion in annual revenue and $1.3 billion in adjusted EBITDA by 2030. If achieved, those targets would establish the platform as one of the largest digital health companies serving consumers directly.
Its growth strategy is not without complications. Expansion into branded weight-loss treatments and international markets has increased costs. Gross margin has declined for several consecutive quarters, and the company swung to a quarterly loss after previously reporting a profit.
The changing regulatory environment surrounding compounded weight-loss medicines is another major issue. Rules affecting semaglutide, peptides and other treatments can influence product availability, pricing and the economics of the weight-management business.
Hims & Hers Health, Inc. (NYSE: HIMS) ranks below the pure-play healthcare AI stocks because artificial intelligence is an important operating capability rather than the company’s primary product. The consumer brand, distribution platform and subscriber relationships remain the main commercial advantages.
Even so, the company’s scale and growth rate are difficult to ignore. If it can protect margins while expanding into additional medical categories, AI-powered personalization could help the business increase revenue per subscriber and improve long-term customer retention.
